UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▲ | Disease Ontology |
---|---|---|---|---|---|
A0A8C6XC27 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A8C6X9H1 | Pannexin |
|
1 | 0 |
|
A0A8C6VQS6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6XZ91 | Beta-secretase 2 |
|
2 | 0 |
|
A0A8C6VMH4 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6X4V0 | Hyaluronidase |
|
1 | 0 |
|
A0A8C6V5U9 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C7E7K6 | Rhodopsin |
|
2 | 0 |
|
A0A8C6Y9R2 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8C7DXE3 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6YB45 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A8C6YFY3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6XD05 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6X438 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A8C6YDZ6 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A8C6YFG6 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6XCY8 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6VDL5 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C6X4R7 | Hyaluronidase |
|
1 | 0 |
|
A0A8C6X314 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8C6XKT8 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C6YG52 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C7E5E8 | Potassium two pore domain channel subfamily K member 16 |
|
1 | 0 |
|
A0A8C7E2Z5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A8C6XY48 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024